Skip to main content
logo
TuHURA Biosciences, Inc. (HURA)
NASDAQ: HURA · Real-Time Price · USD
2.280
-0.190 (-7.69%)
Aug 17, 2026, 4:00 PM EDT - Market closed

TuHURA Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Market Capitalization
14546173--
Market Cap Growth
9.83%-73.43%---
Enterprise Value
15344178--
Last Close Price
2.280.764.09--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
PB Ratio
7.972.1911.85--
P/TBV Ratio
19.404.6312.08--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Debt / Equity Ratio
0.500.030.01-1.500.01
Net Debt / Equity Ratio
0.44-0.14-0.850.85-1.15
Net Debt / EBITDA Ratio
-0.260.100.730.101.48
Net Debt / FCF Ratio
-0.270.110.840.101.87
Quick Ratio
0.110.722.501.114.96
Current Ratio
0.180.783.681.165.13
Return on Equity (ROE)
-161.39%-169.18%-332.67%-545.67%-
Return on Assets (ROA)
-59.96%-74.27%-88.42%-86.58%-
Return on Capital Employed (ROCE)
-141.50%-131.20%-117.60%-1769.90%-80.60%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022
Period Ending
Aug '26 Dec '25 Dec '24 Dec '23 Dec '22
Earnings Yield
-21.10%-65.41%-12.54%--
FCF Yield
-20.59%-60.30%-8.55%--
Buyback Yield / Dilution
-64.72%-156.81%-56.97%--
SEC Filings: 10-K · 10-Q